Novo Nordisk A/SNVONYSE
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
+21.1%/yr
vs +9.5%/yr prior
5Y CAGR
+18.5%/yr
Consistent
Acceleration
+11.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $98.50B | -2.5% |
| 2024 | $100.99B | +20.7% |
| 2023 | $83.68B | +50.7% |
| 2022 | $55.52B | +16.3% |
| 2021 | $47.76B | +13.3% |
| 2020 | $42.14B | +8.2% |
| 2019 | $38.95B | +0.8% |
| 2018 | $38.63B | +1.3% |
| 2017 | $38.13B | +0.5% |
| 2016 | $37.92B | - |